home / stock / rvv:cc / rvv:cc news


RVV:CC News and Press, Revive Therapeutics Ltd - Ordinary Shares From 02/01/24

Stock Information

Company Name: Revive Therapeutics Ltd - Ordinary Shares
Stock Symbol: RVV:CC
Market: CNQC
Website: revivethera.com

Menu

RVV:CC RVV:CC Quote RVV:CC Short RVV:CC News RVV:CC Articles RVV:CC Message Board
Get RVV:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

RVV:CC - Revive Therapeutics Explores the Use of Bucillamine for Long COVID

TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, an...

RVV:CC - Revive Therapeutics Ltd. Announces Closing of the First Tranche of Its Private Placement for Gross Proceeds of $913,500

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- REVIVE THERAPEUTICS LTD. ( CSE: RVV; OTCQB: RVVTF ) (“ Revive ” or the ...

RVV:CC - Revive Therapeutics Ltd. Announces Offering of Up to $3 Million

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- REVIVE THERAPEUTICS LTD. ( CSE: RVV; OTCQB: RVVTF ) (“ Revive ” or the ...

RVV:CC - Revive Therapeutics Provides Update Evaluating Bucillamine for Nerve Agent Exposure with Defence Research and Development Canada

TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, t...

RVV:CC - Revive Therapeutics Successfully Completes Development of a Novel Lyophilized Formulation of Bucillamine

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is...

RVV:CC - Expected Canadian Company Earnings on Friday, December 22nd, 2023

Rock Tech Lithium Inc. (RCK:CA) is expected to report for quarter end 2023-09-30 Strathmore Plus Uranium Corp. (SUU:CA) is expected to report for quarter end 2023-10-31 Terrace Energy Corp. (TZR.H:CA) is expected to report for Q1 2024 FSD Pharma Inc Subordinate Voting Shares (HUGE:CNX...

RVV:CC - Revive Therapeutics Announces Results of Annual General and Special Meeting of Shareholders

TORONTO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“ Revive ” or the “ Company ”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare d...

RVV:CC - Revive Therapeutics Collaborates with Attwill Medical Solutions for the Clinical and Commercial Development of a Novel Lyophilized Formulation of Bucillamine

TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is...

RVV:CC - Expected Canadian Company Earnings on Friday, December 15th, 2023

Belgravia Capital Intl (BLGV:CNX) is expected to report for quarter end 2023-09-30 Novo Resources Corp. (NVO:CA) is expected to report for quarter end 2023-09-30 FSD Pharma Inc Subordinate Voting Shares (HUGE:CNX) is expected to report for Q3 2023 Greenhawk Resources Inc Com (GRHK:CNX...

RVV:CC - Expected Canadian Company Earnings on Friday, December 8th, 2023

Canadian Western Bank (CWB:CA) is expected to report $0.89 for Q4 2023 Verisante Technology Inc. (VER.H:CA) is expected to report for Q1 2024 Imperial Ginseng Products Ltd. (IGP:CA) is expected to report for quarter end 2023-09-30 Western Alaska Minerals Corp. (WAM:CA) is expected to ...

Previous 10 Next 10